Continuous and Daily Oral Immunotherapy for Peanut Allergy: Results from a 2-Year Open-Label Follow-On StudyBrian P. Vickery, Dareen Siri, Stacie M. Jones et al.|The Journal of Allergy and Clinical Immunology In Practice|2020Cited by 89
Sustained Effectiveness, Tolerability, and Safety of Long-Term Prophylaxis with Lanadelumab in Hereditary Angioedema: The Prospective, Phase 4, Noninterventional EMPOWER Real-World StudyJonathan A. Bernstein, Mark Weinstein, Stephen Betschel et al.|Advances in Therapy|2025Cited by 10
Oral berotralstat for hereditary angioedema prophylaxis in patients aged 2 to <12 yearsJolanta Bernatoniene, Emel Aygören‐Pürsün, M. Bourgoin‐Heck et al.|Annals of Allergy Asthma & Immunology|2025Cited by 5